Eagle Pharmaceuticals Inc (EGRX)
0.95
+0.05
(+5.56%)
USD |
OTCM |
Nov 22, 16:00
Eagle Pharmaceuticals Free Cash Flow
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2023 | -9.392M |
| March 31, 2023 | 33.73M |
| December 31, 2022 | 50.52M |
| September 30, 2022 | 21.01M |
| June 30, 2022 | 35.31M |
| March 31, 2022 | 1.023M |
| December 31, 2021 | 27.90M |
| September 30, 2021 | 39.45M |
| June 30, 2021 | 43.82M |
| March 31, 2021 | 56.16M |
| December 31, 2020 | 48.75M |
| September 30, 2020 | 25.83M |
| June 30, 2020 | 30.71M |
| March 31, 2020 | 31.89M |
| December 31, 2019 | 55.21M |
| September 30, 2019 | 96.57M |
| June 30, 2019 | 89.91M |
| March 31, 2019 | 73.35M |
| December 31, 2018 | 52.25M |
| September 30, 2018 | 37.42M |
| Date | Value |
|---|---|
| June 30, 2018 | 40.07M |
| March 31, 2018 | 71.75M |
| December 31, 2017 | 53.73M |
| September 30, 2017 | 64.49M |
| June 30, 2017 | 57.16M |
| March 31, 2017 | 17.10M |
| December 31, 2016 | 32.52M |
| September 30, 2016 | -18.71M |
| June 30, 2016 | -25.41M |
| March 31, 2016 | -35.09M |
| December 31, 2015 | -11.60M |
| September 30, 2015 | -2.203M |
| June 30, 2015 | -1.632M |
| March 31, 2015 | 6.101M |
| December 31, 2014 | -21.79M |
| September 30, 2014 | -13.89M |
| June 30, 2014 | -7.079M |
| March 31, 2014 | -5.172M |
| December 31, 2013 | -4.047M |
| September 30, 2013 | -5.879M |
Free Cash Flow Range, Past 5 Years
-9.392M
Minimum
Jun 2023
56.16M
Maximum
Mar 2021
32.79M
Average
33.73M
Median
Mar 2023
Free Cash Flow Benchmarks
| Eli Lilly and Co | -2.275B |
| Verrica Pharmaceuticals Inc | -59.62M |
| NovaBay Pharmaceuticals Inc | -4.812M |
| Palatin Technologies Inc | -32.57M |
| iBio Inc | -16.93M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -0.126M |
| Cash from Investing (Quarterly) | -0.006M |
| Cash from Financing (Quarterly) | -6.411M |